InsiderTrades.com logo

CSL Insider Trading

Insider Ownership Percentage: 0.30%
Insider Buying (Last 12 Months): A$2,676,300.23
Insider Selling (Last 12 Months): A$1,148,600.00

CSL Insider Trading History Chart

This chart shows the insider buying and selling history at CSL by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CSL Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for CSL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

CSL Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2025Megan ClarkInsiderBuy200A$250.06A$50,012.00
2/19/2025Megan ClarkInsiderBuy132A$264.85A$34,959.94
10/31/2024Paul McKenzieInsiderSell4,000A$287.15A$1,148,600.00
9/3/2024Paul McKenzieInsiderBuy8,275A$306.03A$2,532,398.25
8/16/2024Carolyn HewsonInsiderBuy193A$305.34A$58,930.04
10/20/2023Megan ClarkInsiderBuy210A$237.81A$49,939.05
8/25/2023Robert CuthbertsonInsiderSell20,000A$265.55A$5,310,980.00
8/18/2023Megan ClarkInsiderBuy220A$272.09A$59,858.92
10/24/2022Alison WatkinsInsiderBuy1,000A$272.00A$272,000.00
10/20/2022Megan ClarkInsiderBuy270A$274.01A$73,981.89
9/1/2022Paul PerreaultInsiderSell15,942A$293.41A$4,677,574.10
See Full Table

SEC Filings (Institutional Ownership Changes) for CSL (ASX:CSL)

35.70% of CSL stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CSL logo
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Read More on CSL

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

869,289 shs

Average Volume

N/A

Market Capitalization

$77.43 billion

P/E Ratio

28.02

Dividend Yield

1.56%

Beta

0.32

Who are the company insiders with the largest holdings of CSL?

CSL's top insider investors include:
  1. Carolyn Hewson (Insider)
  2. Megan Clark (Insider)
  3. Paul McKenzie (Insider)
  4. Robert Cuthbertson (Insider)
Learn More about top insider investors at CSL.